Showing results (2701-2710 of 4,128) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|September 10, 2013
Vector sequences are not detected in tumor tissue from research subjects with ornithine transcarbamylase deficiency who previously received adenovirus gene transferLi Zhong, Shaoyong Li, Mengxin Li, et al.Human Gene Therapy|August 31, 2013
Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expressionLisa M McGinley, Jill McMahon, Alessia Stocca, et al.Human Gene Therapy|August 17, 2013
Postentry processing of recombinant adeno-associated virus type 1 and transduction of the ferret lung are altered by a factor in airway secretionsZiying Yan, Xingshen Sun, Idil A Evans, et al.Human Gene Therapy|August 2, 2013
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphomaAlessandra Gavazza, George Lubas, Arthur Fridman, et al.Human Gene Therapy|March 7, 2013
Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humansElizabeth M Parzych, Hua Li, Xiangfan Yin, et al.Human Gene Therapy|March 12, 2013
Novel, small molecule induced GABA-hATSCs for targeting of neuropathic painMin Jee, Young Im, Jee I N Choi, et al.Human Gene Therapy|April 11, 2013
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomesBarbara K Smith, Shelley W Collins, Thomas J Conlon, et al.Human Gene Therapy|December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosisSanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.Human Gene Therapy|May 2, 2012
Efficacy of codelivery of dual AAV2/5 vectors in the murine retina and hippocampusArpad Palfi, Naomi Chadderton, Alex G McKee, et al.Human Gene Therapy|December 1, 2012
Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8Rita Ferla, Thomas O'Malley, Roberto Calcedo, et al.Pageof 413